PROF
PROF
NASDAQ · Health Care

Profound Medical Corp

$6.65
+0.06 (+0.91%)
As of Jul 4, 2:02 AM ET ·
Financial Highlights (FY 2026)
Revenue
28.37M
Net Income
-75,019,318
Gross Margin
70.8%
Profit Margin
-264.4%
Rev Growth
+34.1%
D/E Ratio
0.07
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 70.8% 70.8% 58.7% 58.7%
Operating Margin -256.3% -230.6% 13.1% 12.1%
Profit Margin -264.4% -251.2% 10.1% 13.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 28.37M 21.16M 110.97M 130.03M
Gross Profit 20.08M 14.98M 65.14M 76.33M
Operating Income -72,703,778 -48,809,040 14.49M 15.72M
Net Income -75,019,318 -50,363,558 11.22M 17.35M
Gross Margin 70.8% 70.8% 58.7% 58.7%
Operating Margin -256.3% -230.6% 13.1% 12.1%
Profit Margin -264.4% -251.2% 10.1% 13.3%
Rev Growth +34.1% +34.1% +15.1% +0.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 11.23M 11.23M 159.28M 166.07M
Total Equity 165.91M 165.91M 201.01M 174.26M
D/E Ratio 0.07 0.07 0.79 0.95
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -72,041,134 -51,051,079 16.88M 21.68M
Free Cash Flow 17.89M 15.74M